US Stock MarketDetailed Quotes

CUBT Curative Biotechnology

Watchlist

0.017750
+0.002750+18.33%

15min DelayClose Jun 17 16:00 ET

16.03MMarket Cap-1972P/E (TTM)

Curative Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-49.17%654.84K

-11.24%4.44M

18.13%1.1M

24.74%1.08M

-62.77%963.38K

111.44%1.29M

8.55%5M

-79.52%933.98K

11,430.73%866.3K

13,536.21%2.59M

Selling and administrative expenses

-44.89%412.01K

-53.80%1.95M

-55.04%168.06K

-15.73%622.25K

-83.63%407.7K

22.85%747.65K

-8.41%4.21M

-91.80%373.8K

11,834.17%738.37K

14,009.43%2.49M

-General and administrative expense

-44.89%412.01K

-53.80%1.95M

-55.04%168.06K

-15.73%622.25K

-83.63%407.7K

22.85%747.65K

-8.41%4.21M

-91.80%373.8K

11,834.17%738.37K

14,009.43%2.49M

Research and development costs

-55.30%240.85K

218.51%2.48M

67.19%933.25K

262.36%456.38K

481.97%553.69K

--538.76K

--779.28K

--558.19K

--125.95K

--95.14K

Depreciation amortization depletion

0.00%1.99K

17.97%7.96K

0.00%1.99K

-0.10%1.99K

-0.75%1.99K

161.71%1.99K

27.22%6.74K

50.11%1.99K

50.08%1.99K

51.32%2.01K

-Depreciation and amortization

0.00%1.99K

17.97%7.96K

0.00%1.99K

-0.10%1.99K

-0.75%1.99K

161.71%1.99K

27.22%6.74K

50.11%1.99K

50.08%1.99K

51.32%2.01K

Operating profit

49.17%-654.84K

11.24%-4.44M

-18.13%-1.1M

-24.74%-1.08M

62.77%-963.38K

-111.44%-1.29M

-8.55%-5M

79.52%-933.98K

-11,430.73%-866.3K

-13,536.21%-2.59M

Net non-operating interest income expense

-188.44%-311K

-562.42%-1.17M

-396.52K

-341.87K

-3,945.76%-324.11K

36.07%-107.82K

-411.86%-176.67K

-8.01K

Non-operating interest expense

188.44%311K

562.42%1.17M

--396.52K

--341.87K

3,945.76%324.11K

-36.07%107.82K

411.86%176.67K

--0

--8.01K

Other net income (expense)

100.67%1.11K

-50.46%-2.95K

102.72%4.06K

-417.51%-166.31K

99.54%-1.96K

-149.35K

Special income (charges)

----

97.72%-3.8K

-94.08%-3.8K

--0

----

-417.51%-166.31K

99.54%-1.96K

---149.35K

--0

-Less:Impairment of capital assets

----

-77.59%3.8K

94.08%3.8K

--0

----

-47.23%16.96K

--1.96K

--0

-Less:Other special charges

----

--149.35K

--0

--149.35K

----

Other non- operating income (expenses)

----

--4.91K

--854

--4.06K

----

Income before tax

30.82%-965.84K

-4.95%-5.6M

-60.56%-1.5M

-39.66%-1.42M

50.40%-1.29M

-76.07%-1.4M

-14.35%-5.34M

81.37%-935.94K

-13,418.62%-1.02M

-188,682.11%-2.6M

Income tax

Net income

30.82%-965.84K

-4.95%-5.6M

-60.56%-1.5M

-39.66%-1.42M

50.40%-1.29M

-76.07%-1.4M

-14.35%-5.34M

81.37%-935.94K

-13,418.62%-1.02M

-188,682.11%-2.6M

Net income continuous Operations

30.82%-965.84K

-4.95%-5.6M

-60.56%-1.5M

-39.66%-1.42M

50.40%-1.29M

-76.07%-1.4M

-14.35%-5.34M

81.37%-935.94K

-13,418.62%-1.02M

-188,682.11%-2.6M

Minority interest income

Net income attributable to the parent company

30.82%-965.84K

-4.95%-5.6M

-60.56%-1.5M

-39.66%-1.42M

50.40%-1.29M

-76.07%-1.4M

-14.35%-5.34M

81.37%-935.94K

-13,418.62%-1.02M

-188,682.11%-2.6M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

30.82%-965.84K

-4.95%-5.6M

-60.56%-1.5M

-39.66%-1.42M

50.40%-1.29M

-76.07%-1.4M

-14.35%-5.34M

81.37%-935.94K

-13,418.62%-1.02M

-188,682.11%-2.6M

Basic earnings per share

35.82%-0.0017

-0.72%-0.01

-49.08%-0.0026

-39.67%-0.0026

50.46%-0.381

98.72%-0.0026

99.28%-0.0099

88.47%-0.0017

-8,108.70%-0.0019

-19,228,025.00%-0.7691

Diluted earnings per share

35.82%-0.0017

-0.72%-0.01

-49.08%-0.0026

-39.67%-0.0026

50.46%-0.381

98.72%-0.0026

99.28%-0.0099

88.47%-0.0017

-8,108.70%-0.0019

-19,228,025.00%-0.7691

Dividend per share

Currency Unit

USD

Audit Opinions

Unaudited

	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue	0	0	0	0	0	0	0	0	0	0
Gross profit	0	0	0	0	0	0	0	0	0	0
Operating expense	-49.17%654.84K	-11.24%4.44M	18.13%1.1M	24.74%1.08M	-62.77%963.38K	111.44%1.29M	8.55%5M	-79.52%933.98K	11,430.73%866.3K	13,536.21%2.59M
Selling and administrative expenses	-44.89%412.01K	-53.80%1.95M	-55.04%168.06K	-15.73%622.25K	-83.63%407.7K	22.85%747.65K	-8.41%4.21M	-91.80%373.8K	11,834.17%738.37K	14,009.43%2.49M
-General and administrative expense	-44.89%412.01K	-53.80%1.95M	-55.04%168.06K	-15.73%622.25K	-83.63%407.7K	22.85%747.65K	-8.41%4.21M	-91.80%373.8K	11,834.17%738.37K	14,009.43%2.49M
Research and development costs	-55.30%240.85K	218.51%2.48M	67.19%933.25K	262.36%456.38K	481.97%553.69K	--538.76K	--779.28K	--558.19K	--125.95K	--95.14K
Depreciation amortization depletion	0.00%1.99K	17.97%7.96K	0.00%1.99K	-0.10%1.99K	-0.75%1.99K	161.71%1.99K	27.22%6.74K	50.11%1.99K	50.08%1.99K	51.32%2.01K
-Depreciation and amortization	0.00%1.99K	17.97%7.96K	0.00%1.99K	-0.10%1.99K	-0.75%1.99K	161.71%1.99K	27.22%6.74K	50.11%1.99K	50.08%1.99K	51.32%2.01K
Operating profit	49.17%-654.84K	11.24%-4.44M	-18.13%-1.1M	-24.74%-1.08M	62.77%-963.38K	-111.44%-1.29M	-8.55%-5M	79.52%-933.98K	-11,430.73%-866.3K	-13,536.21%-2.59M
Net non-operating interest income expense	-188.44%-311K	-562.42%-1.17M	-396.52K	-341.87K	-3,945.76%-324.11K	36.07%-107.82K	-411.86%-176.67K	0	0	-8.01K
Non-operating interest expense	188.44%311K	562.42%1.17M	--396.52K	--341.87K	3,945.76%324.11K	-36.07%107.82K	411.86%176.67K	--0	--0	--8.01K
Other net income (expense)		100.67%1.11K	-50.46%-2.95K	102.72%4.06K			-417.51%-166.31K	99.54%-1.96K	-149.35K
Special income (charges)	----	97.72%-3.8K	-94.08%-3.8K	--0	--0	----	-417.51%-166.31K	99.54%-1.96K	---149.35K	--0
-Less:Impairment of capital assets	----	-77.59%3.8K	94.08%3.8K	--0	--0	----	-47.23%16.96K	--1.96K	--0	--0
-Less:Other special charges	----	----	----	----	----	----	--149.35K	--0	--149.35K	----
Other non- operating income (expenses)	----	--4.91K	--854	--4.06K	----	----	----	----	----	----
Income before tax	30.82%-965.84K	-4.95%-5.6M	-60.56%-1.5M	-39.66%-1.42M	50.40%-1.29M	-76.07%-1.4M	-14.35%-5.34M	81.37%-935.94K	-13,418.62%-1.02M	-188,682.11%-2.6M
Income tax
Net income	30.82%-965.84K	-4.95%-5.6M	-60.56%-1.5M	-39.66%-1.42M	50.40%-1.29M	-76.07%-1.4M	-14.35%-5.34M	81.37%-935.94K	-13,418.62%-1.02M	-188,682.11%-2.6M
Net income continuous Operations	30.82%-965.84K	-4.95%-5.6M	-60.56%-1.5M	-39.66%-1.42M	50.40%-1.29M	-76.07%-1.4M	-14.35%-5.34M	81.37%-935.94K	-13,418.62%-1.02M	-188,682.11%-2.6M
Minority interest income
Net income attributable to the parent company	30.82%-965.84K	-4.95%-5.6M	-60.56%-1.5M	-39.66%-1.42M	50.40%-1.29M	-76.07%-1.4M	-14.35%-5.34M	81.37%-935.94K	-13,418.62%-1.02M	-188,682.11%-2.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	30.82%-965.84K	-4.95%-5.6M	-60.56%-1.5M	-39.66%-1.42M	50.40%-1.29M	-76.07%-1.4M	-14.35%-5.34M	81.37%-935.94K	-13,418.62%-1.02M	-188,682.11%-2.6M
Basic earnings per share	35.82%-0.0017	-0.72%-0.01	-49.08%-0.0026	-39.67%-0.0026	50.46%-0.381	98.72%-0.0026	99.28%-0.0099	88.47%-0.0017	-8,108.70%-0.0019	-19,228,025.00%-0.7691
Diluted earnings per share	35.82%-0.0017	-0.72%-0.01	-49.08%-0.0026	-39.67%-0.0026	50.46%-0.381	98.72%-0.0026	99.28%-0.0099	88.47%-0.0017	-8,108.70%-0.0019	-19,228,025.00%-0.7691
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unaudited	--	--	--	--	Unaudited	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall